Researcher Jonathan Wall, PhD, with The University of Tennessee Health Science Center Receives $1 Million to Study Antibody Therapy for Systemic Amyloid Disease
|The amyloidoses are a group of rare diseases that are a consequence of abnormal protein (amyloid) deposits in various body tissues and organs. Characterized as systemic or localized, light chain-associated amyloidosis (AL) is the most common form of systemic amyloid disease, with an estimated 4,500 new cases each year in the United States. Systemic amyloid… Read More